Results 11 to 20 of about 2,999 (125)

Changing trends in prenatal screening and treatment of cytomegalovirus infection in France: 7‐year national cohort study (2017–2023)

open access: yesUltrasound in Obstetrics &Gynecology, Volume 67, Issue 6, Page 756-763, June 2026.
ABSTRACT Objectives Cytomegalovirus (CMV) is the leading cause of congenital infectious neurosensory impairment. We aimed to present national epidemiological data on maternal CMV infection during pregnancy in France, focusing in particular on primary infection in the periconceptional period or first trimester, and to assess the impact of changes in ...
P. Coste‐Mazeau   +176 more
wiley   +1 more source

Predictive performance of Fetal Medicine Foundation first‐trimester screening algorithm for pre‐eclampsia according to conception mode

open access: yesUltrasound in Obstetrics &Gynecology, Volume 67, Issue 6, Page 806-814, June 2026.
ABSTRACT Objective To investigate the incidence of pre‐eclampsia (PE) and the predictive performance of the Fetal Medicine Foundation (FMF) first‐trimester PE screening algorithm across pregnancies conceived using assisted reproductive technology (ART), after ovulation induction (OI) and through spontaneous conception (SC).
A. S. L. Kjaer   +23 more
wiley   +1 more source

First‐trimester prediction and prevention of preterm pre‐eclampsia in women with chronic hypertension

open access: yesUltrasound in Obstetrics &Gynecology, Volume 67, Issue 5, Page 613-622, May 2026.
ABSTRACT Objectives To evaluate the effect of aspirin on gestational age at delivery due to preterm pre‐eclampsia (PE) in women with chronic hypertension (CH), to assess the predictive performance of the Fetal Medicine Foundation (FMF) first‐trimester competing‐risks model for preterm PE in this high‐risk group and to evaluate how parity, previous PE ...
D. L. Rolnik   +23 more
wiley   +1 more source

Longitudinal maternal hemodynamics in high‐risk pregnancies with different subtypes of pre‐eclampsia

open access: yesUltrasound in Obstetrics &Gynecology, Volume 67, Issue 5, Page 623-634, May 2026.
ABSTRACT Objective To evaluate maternal cardiac adaptation during pregnancy by comparing longitudinal hemodynamic profiles between women identified as high risk for preterm pre‐eclampsia (PE) who subsequently developed preterm PE, term PE or remained unaffected, as well as low‐risk women.
J. Lin   +10 more
wiley   +1 more source

Perinatal outcomes of twin pregnancies complicated by early twin‐to‐twin transfusion syndrome treated with fetoscopic laser surgery

open access: yesUltrasound in Obstetrics &Gynecology, Volume 67, Issue 4, Page 461-469, April 2026.
ABSTRACT Objective The aim of this study was to evaluate the perinatal outcomes of monochorionic diamniotic (MCDA) twin pregnancies complicated by early twin‐to‐twin transfusion syndrome (TTTS) treated with fetoscopic laser surgery (FLS), and to compare rates of fetal survival across Quintero stages.
F. G. Sileo   +35 more
wiley   +1 more source

Predictive value of gB2 antibodies for maternal–fetal transmission after primary cytomegalovirus infection treated with valacyclovir

open access: yesUltrasound in Obstetrics &Gynecology, Volume 67, Issue 4, Page 455-460, April 2026.
ABSTRACT Objective To estimate the residual risk of maternal–fetal transmission after primary cytomegalovirus (CMV) infection in the periconceptional period or the first trimester in women treated with valacyclovir, and to assess whether the presence of glycoprotein B2 (gB2)‐specific immunoglobulin (Ig)‐G antibodies on immunoblot analysis refines fetal
K. O. Kagan   +6 more
wiley   +1 more source

Placental insufficiency markers to assess the risk of non‐chromosomal genetic conditions in early‐onset fetal growth restriction

open access: yesUltrasound in Obstetrics &Gynecology, Volume 67, Issue 4, Page 492-499, April 2026.
ABSTRACT Objectives To assess the value of placental insufficiency markers for estimating the risk of genetic anomalies in fetuses with isolated early‐onset fetal growth restriction (FGR), defined as an estimated fetal weight ≤ 3rd percentile diagnosed ≤ 28 + 6 weeks' gestation.
M. Armengol‐Alsina   +17 more
wiley   +1 more source

Multiple pregnancy with complete hydatidiform mole and coexisting normal fetus: systematic review and meta‐analysis of clinical outcomes from non‐randomized studies

open access: yesUltrasound in Obstetrics &Gynecology, Volume 67, Issue 3, Page 272-282, March 2026.
ABSTRACT Objective Complete hydatidiform mole and coexisting normal fetus (CHMCF) is a rare condition for which there is significant heterogeneity in diagnosis, counseling and management of complications. The objective of this study was to summarize the prevalence of clinical outcomes in reported cases of CHMCF.
N. Salmeri   +8 more
wiley   +1 more source

Ultrasound features in early pregnancy for predicting abnormal karyotype in first‐trimester miscarriage

open access: yesUltrasound in Obstetrics &Gynecology, Volume 67, Issue 3, Page 376-384, March 2026.
ABSTRACT Objective To investigate whether combining abnormal morphological features observed on ultrasound in live pregnancies that ended in a first‐trimester miscarriage can predict an abnormal karyotype. Methods This retrospective observational cohort study was conducted at the early‐pregnancy assessment unit at University College London Hospital ...
T. Setty   +5 more
wiley   +1 more source

Fetoscopic laser ablation vs standard management for Type‐II and Type‐III vasa previa

open access: yesUltrasound in Obstetrics &Gynecology, Volume 67, Issue 3, Page 320-328, March 2026.
ABSTRACT Objective The standard management (SM) for vasa previa (VP) includes antepartum inpatient admission at 28–32 weeks' gestation followed by Cesarean delivery at 34–37 weeks. Case reports and case series have reported on fetoscopic laser ablation (FLA) as an alternative management approach for Types‐II and ‐III VP.
S. Backley   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy